CD79A and irritable bowel syndrome: Whereas the prevalence of anti-gluten antibodies in CD and IBS patients has been described before [10,20], studies regarding the humoral immune response (specific IgA and IgG antibodies) to maize prolamins in CD and IBS patients are lacking.